Peter H. Andersen

Peter Hongaard Andersen is an experienced professional in the biotechnology and pharmaceutical sectors, currently serving as an Operating Partner at Forbion since April 2022 and as a member of the board of directors at Immunovia AB. With expertise as an independent consultant through Hongaard Consulting since June 2019, Peter has held leadership roles such as Chairman of the Board at Edvince AB and Scandion Oncology, and Venture Partner at Ysios Capital. Additionally, Peter contributed to innovation initiatives as Chairman of the Innovation Board for the Association of Danish Regions and led the InnoExplorer panel at Innovation Fund Denmark. Peter's earlier career includes significant positions at Lundbeck, culminating in roles such as SVP of Global Public Affairs and Corporate Patents and Trademarks, and CEO of the European Brain Council.